Actively Recruiting
Evaluation of the Efficacy of STNS With FAST and MULTIWAVE in Patients With Refractory Chronic Neuropathic Pain
Led by Poitiers University Hospital · Updated on 2026-02-17
17
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of the study is to demonstrate Spinal Transforaminal NeuroStimulation effectiveness with FAST and other waveforms / combinations to relief neuropathic peripheral pain in chronic neuropathic pain patients, at low risk and low energy consumption.
CONDITIONS
Official Title
Evaluation of the Efficacy of STNS With FAST and MULTIWAVE in Patients With Refractory Chronic Neuropathic Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject is between 18 and 80 years old
- Subject has a global Visual Analogic Scale score of 5 or higher
- Subject has non-cancer pain with a significant neuropathic component lasting at least 6 months
- Subject has had stable pain for at least 30 days
- Pain medication doses have been stable for at least 30 days
- Subject is eligible for Spinal Transforaminal NeuroStimulation after assessment by a multidisciplinary team
- Subject understands and accepts study constraints and can use the equipment
- Patient is covered by French national health insurance
- Subject has given written informed consent after receiving full information
You will not qualify if you...
- Subject has a coagulation disorder
- Subject is or has been treated with spinal cord stimulation, subcutaneous or peripheral nerve stimulation, or an intrathecal drug delivery system
- Subject has had corticosteroid therapy within the past 30 days
- Subject has had radiofrequency therapy within the past 3 months
- Subject has been diagnosed with cancer within the past 2 years
- Subject has had spinal surgery within the past 6 months
- Subject is participating simultaneously in any interventional study that may interfere with this study
- Subject has brain MRI contraindications such as intracranial clips, pacemaker, defibrillator, implanted neurostimulator not MRI compatible, or other listed metallic implants
- Subject requires special legal protection or is in an emergency setting
- Pregnant or breastfeeding women, women able to conceive and not using effective contraception
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Poitiers University Hospital
Poitiers, France, France, 86000
Actively Recruiting
Research Team
P
Philippe Rigoard, MD, PhD
CONTACT
M
Manuel ROULAUD, MS, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here